Nice work Megagene79
I found the results of the 20 year study done on those dwarfism subjects really interesting and obviously really supporting and validating the tie in between IGF levels and diseases (hence confirming the potential for ATL1103)
Also found the instances of lower IGF levels in the centurian age group folks interesting and didn't realise the significance until then.
And that it's all genetic in that those who lived to 100 years old often did so, as well as family members, due to the common link to IGF levels again, and most were of modest to average height as a basic common. Can't remember the group, but was a socially isolated one from memory
He said he couldn't see ATL1103 being approved as a treatment for "treating old age" but it was a likely pleasant side effect of those treated with the drug, to treat other disorders, which I found quite amusing (and wishful thinking)
Typing this as I try and keep one ear on a conference call, so excuse any grammatical shortcomings
- Forums
- ASX - By Stock
- PER
- melbourne presentation
melbourne presentation, page-3
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.5¢ |
Change
-0.001(1.16%) |
Mkt cap ! $88.12M |
Open | High | Low | Value | Volume |
8.6¢ | 8.8¢ | 8.5¢ | $290.3K | 3.355M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 322623 | 8.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.8¢ | 227962 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 322623 | 0.085 |
1 | 200000 | 0.083 |
2 | 29125 | 0.082 |
4 | 326000 | 0.081 |
9 | 925186 | 0.080 |
Price($) | Vol. | No. |
---|---|---|
0.088 | 227962 | 2 |
0.089 | 200000 | 1 |
0.090 | 604764 | 4 |
0.092 | 200000 | 1 |
0.093 | 200000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online